Literature DB >> 29142596

Role and underlying mechanisms of the interstitial protein periostin in the diagnosis and treatment of malignant tumors.

Dong Ye1, Zhi Sen Shen1, Shi Jie Qiu1, Qun Li1, Guo Li Wang1.   

Abstract

Invasion and metastasis are the major characteristics of malignant tumors and are complex processes involving multiple genes. Gene regulation is a precise, large and complex biological control system, and its underlying mechanisms remain to be elucidated. Mesenchymal-specific genes are expressed primarily by mesenchymal cells, and the expression products of these genes are molecules with various structures and functions, including secreted proteins and extracellular matrix proteins. The periostin gene has been newly identified as a mesenchymal-specific gene and an extracellular-matrix secreted protein. Periostin is able to bind to various subtypes of integrin receptors on the surface of the cell membrane. This triggers relevant signal transduction pathways to alter the microenvironment of cancer cells in order to facilitate their survival, invasion, metastasis and angiogenesis as well as enhance the tolerance to hypoxia and chemicals. Therefore, periostin is associated with the grade of malignancy, level of invasion and prognosis of malignant tumors. The in-depth study of periostin may provide an effective marker for tumor diagnosis and prognosis, as well as a novel treatment target.

Entities:  

Keywords:  diagnosis; mechanism; oncology; periostin; therapy

Year:  2017        PMID: 29142596      PMCID: PMC5666658          DOI: 10.3892/ol.2017.6866

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  61 in total

1.  MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells.

Authors:  Guang Zeng; Wenxing Xun; Kewen Wei; Yongjin Yang; Huan Shen
Journal:  Oncol Rep       Date:  2016-07-07       Impact factor: 3.906

2.  Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.

Authors:  Pedram Heidari; Shadi A Esfahani; Nazife S Turker; Gabrielle Wong; Timothy C Wang; Anil K Rustgi; Umar Mahmood
Journal:  J Nucl Med       Date:  2015-06-11       Impact factor: 10.057

3.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

4.  Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.

Authors:  Hidefumi Sasaki; Chih-Yi Yu; Meiru Dai; Carmen Tam; Massimo Loda; Daniel Auclair; Lan Bo Chen; Anthony Elias
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

5.  Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells.

Authors:  Daniel L Coutu; Jian Hui Wu; Anne Monette; Georges-Etienne Rivard; Mark D Blostein; Jacques Galipeau
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

6.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

Authors:  Shideng Bao; Gaoliang Ouyang; Xuefang Bai; Zhi Huang; Chaoyu Ma; Ming Liu; Rong Shao; Ryan M Anderson; Jeremy N Rich; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

7.  High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Y Lv; W Wang; W D Jia; Q K Sun; M Huang; H C Zhou; H H Xia; W B Liu; H Chen; S N Sun; G L Xu
Journal:  Eur J Surg Oncol       Date:  2013-07-31       Impact factor: 4.424

8.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.

Authors:  Go Takayama; Kazuhiko Arima; Taisuke Kanaji; Shuji Toda; Hiroyuki Tanaka; Shunsuke Shoji; Andrew N J McKenzie; Hiroichi Nagai; Takao Hotokebuchi; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

9.  Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells.

Authors:  Gaëlle Tilman; Marina Mattiussi; Francis Brasseur; Nicolas van Baren; Anabelle Decottignies
Journal:  Mol Cancer       Date:  2007-12-17       Impact factor: 27.401

10.  Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.

Authors:  Yang Liu; Fan Li; Feng Gao; Lingxi Xing; Peng Qin; Xingxin Liang; Jiajie Zhang; Xiaohui Qiao; Lizhou Lin; Qian Zhao; Lianfang Du
Journal:  Oncotarget       Date:  2016-06-28
View more
  1 in total

1.  Periostin expression in neoplastic and non-neoplastic diseases of bone and joint.

Authors:  Jennifer M Brown; Akiro Mantoku; Afsie Sabokbar; Udo Oppermann; A Bass Hassan; Akiro Kudo; Nick Athanasou
Journal:  Clin Sarcoma Res       Date:  2018-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.